Business Description
NuGen Medical Devices Inc
NAICS : 423450
SIC : 3912
ISIN : CA67054F1009
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.49 | |||||
Equity-to-Asset | -0.43 | |||||
Debt-to-Equity | -2.91 | |||||
Debt-to-EBITDA | -3.26 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -3.53 | |||||
Beneish M-Score | -2.12 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 26 | |||||
3-Year EBITDA Growth Rate | -13.6 | |||||
3-Year EPS without NRI Growth Rate | -6.8 | |||||
3-Year FCF Growth Rate | -35.7 | |||||
3-Year Book Growth Rate | -7.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 16.56 | |||||
9-Day RSI | 29.57 | |||||
14-Day RSI | 36.13 | |||||
6-1 Month Momentum % | -25 | |||||
12-1 Month Momentum % | -25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.12 | |||||
Quick Ratio | 3.01 | |||||
Cash Ratio | 2.89 | |||||
Days Inventory | 243.69 | |||||
Days Sales Outstanding | 14.93 | |||||
Days Payable | 951.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -32.3 | |||||
Shareholder Yield % | -19.12 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 46.92 | |||||
Operating Margin % | -849.02 | |||||
Net Margin % | -1089.12 | |||||
FCF Margin % | -415.33 | |||||
ROA % | -95.87 | |||||
ROIC % | -90.57 | |||||
ROC (Joel Greenblatt) % | -28754.39 | |||||
ROCE % | -116.63 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 25 | |||||
EV-to-EBIT | -4 | |||||
EV-to-EBITDA | -4.44 | |||||
EV-to-Revenue | 34.39 | |||||
EV-to-FCF | -8.63 | |||||
Earnings Yield (Greenblatt) % | -24.98 | |||||
FCF Yield % | -19.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
NuGen Medical Devices Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 0.763 | ||
EPS (TTM) (C$) | -0.035 | ||
Beta | 2.57 | ||
Volatility % | 60.9 | ||
14-Day RSI | 36.13 | ||
14-Day ATR (C$) | 0.005446 | ||
20-Day SMA (C$) | 0.08875 | ||
12-1 Month Momentum % | -25 | ||
52-Week Range (C$) | 0.075 - 0.155 | ||
Shares Outstanding (Mil) | 217.73 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
NuGen Medical Devices Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
NuGen Medical Devices Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
NuGen Medical Devices Inc Frequently Asked Questions
What is NuGen Medical Devices Inc(TSXV:NGMD)'s stock price today?
When is next earnings date of NuGen Medical Devices Inc(TSXV:NGMD)?
Does NuGen Medical Devices Inc(TSXV:NGMD) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |